Accord BioPharma’s IMULDOSA® (ustekinumab-srlf) Added to Express Scripts National Commercial Formularies
Company's immunology franchise demonstrates strong market momentum with preferred status under one of the largest pharmacy benefit managers in the nation Accord BioPharma Inc., the specialty division of Intas Pharmaceuticals, Ltd., focused on the development of oncology, immunology, and critical care therapies, announced that Express Scripts, one of the nation's largest pharmacy benefit managers, has […]